Cargando…
Stage III Non–Small-Cell Lung Cancer Treated With Concurrent Chemoradiation Followed or Not by Consolidation Chemotherapy: A Survival Analysis From a Brazilian Multicentric Cohort
PURPOSE: Of newly diagnosed patients with non–small-cell lung cancer (NSCLC), stage III accounts for 30%. Most patients are treated with concurrent chemoradiation therapy, but the addition of consolidation chemotherapy (CC) is debatable. We examined the effect of CC in Brazilian patients with stage...
Autores principales: | Cordeiro de Lima, Vladmir C., Baldotto, Clarissa S., Barrios, Carlos H., Sobrinho, Eldsamira M., Zukin, Mauro, Mathias, Clarissa, Zaffaroni, Facundo, Nery, Rodrigo C., Madeira, Gabriel, Amadio, Alex V., Coelho, Juliano C., Geib, Guilherme, Simões, Maria Fernanda, Castro, Gilberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Clinical Oncology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223524/ https://www.ncbi.nlm.nih.gov/pubmed/30241276 http://dx.doi.org/10.1200/JGO.17.00214 |
Ejemplares similares
-
Comprehensive genomic profiling of Brazilian non‐small cell lung cancer patients (GBOT 0118/LACOG0418)
por: Mascarenhas, Eldsamira, et al.
Publicado: (2020) -
Lung Cancer and the COVID-19 pandemic: Recommendations from the Brazilian Thoracic Oncology Group
por: Baldotto, Clarissa, et al.
Publicado: (2020) -
Assessing Oncologists’ Attitudes Concerning Comprehensive Genomic Profiling in Stage IV Lung Adenocarcinoma in Brazil
por: Fares, Aline F., et al.
Publicado: (2022) -
Lung cancer in Brazil
por: Araujo, Luiz Henrique, et al.
Publicado: (2018) -
EGFR Mutation Detection in Brazilian Patients With Non–Small-Cell Lung Cancer: Lessons From Real-World Data Scenario of Molecular Testing
por: Montella, Tatiane, et al.
Publicado: (2023)